Medicis Announces Third Quarter 2009 Conference Call and Webcast
November 02, 2009 08:00 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Nov. 2, 2009 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced it expects to report 2009 third quarter financial results after the market closes on Wednesday, November 4, 2009....
Medicis Receives Notice of Allowance for SOLODYN(R) Patent
October 13, 2009 16:05 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Oct. 13, 2009 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for Medicis' United...
Medicis to Present At UBS Global Life Sciences Conference
September 17, 2009 08:00 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Sept. 17, 2009 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the UBS Global Life Sciences Conference in New York City. A live...
Medicis Declares Cash Dividend
September 16, 2009 08:00 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Sept. 16, 2009 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that its Board of Directors declared a quarter-end cash dividend of $0.04 per issued and outstanding share of...
Medicis to Present At Morgan Stanley Global Healthcare Conference
September 10, 2009 08:00 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Sept. 10, 2009 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the Morgan Stanley Global Healthcare Unplugged Conference in New...
Medicis to Present At Thomas Weisel Partners Healthcare Conference
September 08, 2009 08:00 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Sept. 8, 2009 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the Thomas Weisel Partners Annual Healthcare Conference in Boston,...
Medicis Reports Second Quarter 2009 Financial Results
August 05, 2009 16:05 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Aug. 5, 2009 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced record net revenues of approximately $141.2 million for the three months ended June 30, 2009, compared to net...
Medicis Announces Second Quarter 2009 Conference Call and Webcast
July 31, 2009 08:00 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., July 31, 2009 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced it expects to report 2009 second quarter financial results after the market closes on Wednesday, August 5, 2009....
Medicis and Revance Announce Agreement for Development of Next-Gen Neurotoxin
July 28, 2009 16:34 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz. and NEWARK, Calif., July 28, 2009 (GLOBE NEWSWIRE) -- Medicis Pharmaceutical Corporation (NYSE:MRX) (Medicis) and Revance Therapeutics, Inc. (Revance) today announced that the...
Medicis Announces Approval of New Strengths of SOLODYN(R)
July 27, 2009 16:05 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., July 27, 2009 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the U.S. Food and Drug Administration (FDA) has approved additional strengths of SOLODYN(R) (minocycline...